Clinical Trial Update: IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on IGFBP-2 vaccine with combination chemotherapy for stage III-IV ovarian, fallopian tube, or primary peritoneal cancer undergoing surgery;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Combination chemotherapy
• IGFBP-2 vaccine (IGFBP-2 vaccine)

Snippet

Sponsor: University of Washington | Conditions: Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-01-14